Funding for biodefense and pandemic preparedness medical countermeasures
2025 · 1st Quarter (Jan 1 - Mar 31)
CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS
Filed by STRATEGIC MARKETING INNOVATIONS.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- STRATEGIC MARKETING INNOVATIONS
- Filing UUID
- e0fe5feb-b8a6-4202-aae8-399b821e8f0b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Funding for biodefense and pandemic preparedness medical countermeasures
Funding for biodefense and pandemic preparedness medical countermeasures
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.